IFNA2 and myasthenia gravis: However, IFN‐I auto‐Abs can also be identified in patients without genetic abnormalities related to IFN‐I immunity, such as in patients with systemic lupus, thymoma or myasthenia gravis, or treated with IFN‐α or IFN‐β.5